Pharmacology
All Targets
7-TM Receptors
Ion Channels
Nuclear Receptors
Enzyme-Linked Receptors
Transporters
Enzymes
Other Pharmacology
Cellular Processes
Angiogenesis
Apoptosis
Cell Cycle
Cell Metabolism
Cytoskeleton & Motor Proteins
ECM & Adhesion Molecules
Epigenetics
Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
Lipid Metabolism
More Information »When glucose supplies are low, the body is able to draw upon lipids as an alternative energy source. Lipids are generally stored as triglycerides and the first step in lipid metabolism is the conversion to glycerol and fatty acids which then enter the Krebs cycle.
Lipid Metabolism Products
Inhibitors |
|
Cat.No. |
Product Name / Activity |
| 0484 | Dioctanoylglycol |
| Diacylglycerol kinase inhibitor | |
| 4444 | Fatostatin A |
| Cell permeable inhibitor of SREBP activation | |
| 3354 | PF 429242 |
| Competitive inhibitor of SREBP site 1 protease | |
| 4847 |
PluriSln 1
|
| Inhibitor of SCD1; selectively eliminates undifferentiated hPSCs from culture | |
| 2194 | R 59-022 |
| Diacylglycerol kinase inhibitor; increases PKC activity | |
| 1842 | RHC 80267 |
| Diacylglycerol lipase inhibitor | |
| 4189 | SC 26196 |
| Selective Δ6 desaturase inhibitor | |
| 3711 | SK1-I |
| Sphingosine kinase 1 inhibitor | |
| 2097 | SKI II |
| Selective non-lipid inhibitor of sphingosine kinase; antitumor | |
| 4184 | Torcetrapib |
| Inhibitor of cholesteryl ester transfer protein (CETP) | |
Other |
|
Cat.No. |
Product Name / Activity |
| 0355 | (±)-Acetylcarnitine chloride |
| Intermediate in lipid metabolism | |
| 2784 | Acipimox |
| Antilipolytic agent | |
| 2756 | Arachidonic acid (in Tocrisolve™100) |
| Endogenous free fatty acid (in water-soluble emulsion) | |
| 0477 | (±)-Decanoylcarnitine chloride |
| Intermediate in lipid metabolism | |
| 4378 | DLPC |
| LRH-1 agonist; regulates bile acid metabolism | |
| 0526 | (±)-Hexanoylcarnitine chloride |
| Intermediate in lipid metabolism | |
| 0548 | (±)-Lauroylcarnitine chloride |
| Intermediate in lipid metabolism | |
| 0567 | (±)-Myristoylcarnitine chloride |
| Intermediate in lipid metabolism | |
| 0605 | (±)-Octanoylcarnitine chloride |
| Intermediate in lipid metabolism | |
| 0878 | Oleamide |
| Sleep-inducing brain lipid | |
| 1484 | Oleylethanolamide |
| Lipid mediator, anorexic actions. Also GPR55 and PPARα agonist | |
| 0609 | (±)-Palmitoylcarnitine chloride |
| Intermediate in fatty acid oxidation | |
| 0611 | (±)-Propionylcarnitine chloride |
| Intermediate in lipid metabolism | |
Related Categories
Quick Order
Find multiple products by catalog number
Tocris Events
Win a Kindle
British Cardiovascular Society Annual Conference 2013
June 3 - 5, 2013
London, UK
Booth Number: C54

